These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 25238820)

  • 1. [Contribution of omega-3 fatty acids for memory and cognitive function].
    Waitzberg DL; Garla P
    Nutr Hosp; 2014 Sep; 30(3):467-77. PubMed ID: 25238820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No Effect of Omega-3 Fatty Acid Supplementation on Cognition and Mood in Individuals with Cognitive Impairment and Probable Alzheimer's Disease: A Randomised Controlled Trial.
    Phillips MA; Childs CE; Calder PC; Rogers PJ
    Int J Mol Sci; 2015 Oct; 16(10):24600-13. PubMed ID: 26501267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower omega-3 fatty acid intake and status are associated with poorer cognitive function in older age: A comparison of individuals with and without cognitive impairment and Alzheimer's disease.
    Phillips MA; Childs CE; Calder PC; Rogers PJ
    Nutr Neurosci; 2012 Nov; 15(6):271-7. PubMed ID: 22824373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omega-3 fatty acids' supplementation in Alzheimer's disease: A systematic review.
    Canhada S; Castro K; Perry IS; Luft VC
    Nutr Neurosci; 2018 Oct; 21(8):529-538. PubMed ID: 28466678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice.
    Arendash GW; Jensen MT; Salem N; Hussein N; Cracchiolo J; Dickson A; Leighty R; Potter H
    Neuroscience; 2007 Oct; 149(2):286-302. PubMed ID: 17904756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ω-3 fatty acids in the prevention of cognitive decline in humans.
    Cederholm T; Salem N; Palmblad J
    Adv Nutr; 2013 Nov; 4(6):672-6. PubMed ID: 24228198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
    Freund-Levi Y; Eriksdotter-Jönhagen M; Cederholm T; Basun H; Faxén-Irving G; Garlind A; Vedin I; Vessby B; Wahlund LO; Palmblad J
    Arch Neurol; 2006 Oct; 63(10):1402-8. PubMed ID: 17030655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary Approaches and Supplements in the Prevention of Cognitive Decline and Alzheimer's Disease.
    Dominguez LJ; Barbagallo M
    Curr Pharm Des; 2016; 22(6):688-700. PubMed ID: 26635270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study.
    Chiu CC; Su KP; Cheng TC; Liu HC; Chang CJ; Dewey ME; Stewart R; Huang SY
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1538-44. PubMed ID: 18573585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homocysteine Status Modifies the Treatment Effect of Omega-3 Fatty Acids on Cognition in a Randomized Clinical Trial in Mild to Moderate Alzheimer's Disease: The OmegAD Study.
    Jernerén F; Cederholm T; Refsum H; Smith AD; Turner C; Palmblad J; Eriksdotter M; Hjorth E; Faxen-Irving G; Wahlund LO; Schultzberg M; Basun H; Freund-Levi Y
    J Alzheimers Dis; 2019; 69(1):189-197. PubMed ID: 30958356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NIH state-of-the-science conference statement: Preventing Alzheimer's disease and cognitive decline.
    Daviglus ML; Bell CC; Berrettini W; Bowen PE; Connolly ES; Cox NJ; Dunbar-Jacob JM; Granieri EC; Hunt G; McGarry K; Patel D; Potosky AL; Sanders-Bush E; Silberberg D; Trevisan M
    NIH Consens State Sci Statements; 2010 Apr; 27(4):1-30. PubMed ID: 20445638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omega-3 Fatty Acids: Repurposing Opportunities for Cognition and Biobehavioral Disturbances in MCI and Dementia.
    Knöchel C; Voss M; Gruter F; Alves GS; Matura S; Sepanski B; Stablein M; Kraft D; Prvulovic D; Carvalho AF; Reif A; Oertel-Knochel V
    Curr Alzheimer Res; 2017; 14(3):240-254. PubMed ID: 27335040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Relationship of Omega-3 Fatty Acids with Dementia and Cognitive Decline: Evidence from Prospective Cohort Studies of Supplementation, Dietary Intake, and Blood Markers.
    Wei BZ; Li L; Dong CW; Tan CC; ; Xu W
    Am J Clin Nutr; 2023 Jun; 117(6):1096-1109. PubMed ID: 37028557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omega-3 fatty acids and brain resistance to ageing and stress: body of evidence and possible mechanisms.
    Denis I; Potier B; Vancassel S; Heberden C; Lavialle M
    Ageing Res Rev; 2013 Mar; 12(2):579-94. PubMed ID: 23395782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omega-3 fatty acids and cognitive function.
    Welty FK
    Curr Opin Lipidol; 2023 Feb; 34(1):12-21. PubMed ID: 36637075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omega-3 fatty acids and blood-based biomarkers in Alzheimer's disease and mild cognitive impairment: A randomized placebo-controlled trial.
    Lin PY; Cheng C; Satyanarayanan SK; Chiu LT; Chien YC; Chuu CP; Lan TH; Su KP
    Brain Behav Immun; 2022 Jan; 99():289-298. PubMed ID: 34755655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of long-term omega-3 fatty acid supplementation on cognition and Alzheimer's pathology in animal models of Alzheimer's disease: a systematic review and meta-analysis.
    Hooijmans CR; Pasker-de Jong PC; de Vries RB; Ritskes-Hoitinga M
    J Alzheimers Dis; 2012; 28(1):191-209. PubMed ID: 22002791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial.
    Sinn N; Milte CM; Street SJ; Buckley JD; Coates AM; Petkov J; Howe PR
    Br J Nutr; 2012 Jun; 107(11):1682-93. PubMed ID: 21929835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased intermediate M1-M2 macrophage polarization and improved cognition in mild cognitive impairment patients on ω-3 supplementation.
    Famenini S; Rigali EA; Olivera-Perez HM; Dang J; Chang MT; Halder R; Rao RV; Pellegrini M; Porter V; Bredesen D; Fiala M
    FASEB J; 2017 Jan; 31(1):148-160. PubMed ID: 27677546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fish consumption and omega-3 fatty acid supplementation for prevention or treatment of cognitive decline, dementia or Alzheimer's disease in older adults - any news?
    Cederholm T
    Curr Opin Clin Nutr Metab Care; 2017 Mar; 20(2):104-109. PubMed ID: 27977429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.